Olympic Steel (ZEUS) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
The annual meeting will be held virtually on May 2, 2025, with shareholders voting on director elections, auditor ratification, and executive compensation approval.
Shareholders of record as of March 10, 2025, are entitled to vote, with 11,162,704 shares outstanding.
The Board recommends voting in favor of all proposals and director nominees.
Voting matters and shareholder proposals
Shareholders will vote to elect five directors for a two-year term expiring in 2027.
Ratification of Grant Thornton LLP as independent auditors for 2025 is on the agenda.
Advisory approval of named executive officer compensation (say-on-pay) is included.
Shareholder proposals for the 2026 meeting must be submitted by November 28, 2025.
Board of directors and corporate governance
The Board is divided into two classes with staggered two-year terms.
All director nominees have significant industry, financial, or governance experience.
The Board has Audit, Compensation, and Nominating & Governance Committees, all composed of independent directors.
A Lead Director position exists to enhance board independence and risk oversight.
Majority voting policy requires directors receiving more withhold than for votes to tender resignations.
Latest events from Olympic Steel
- Shareholders will vote on a merger with Ryerson, with supplemental disclosures addressing litigation.ZEUS
Proxy Filing2 Feb 2026 - Q2 2024 profit held across all segments despite lower sales and steep steel price declines.ZEUS
Q2 20242 Feb 2026 - Q3 2024 profit dropped to $2.7M on lower sales, but all segments remained EBITDA-positive.ZEUS
Q3 202417 Jan 2026 - Shareholders to vote on all-stock merger creating a leading North American metals service center.ZEUS
Proxy Filing14 Jan 2026 - Strategic acquisitions and product diversification position the company for robust midterm growth.ZEUS
Sidoti Small-Cap Virtual Conference26 Dec 2025 - Q4 saw sequential earnings growth, positive EBITDA, and strategic expansion via acquisition.ZEUS
Q4 202423 Dec 2025 - Shelf registration for $200M in securities supports growth, with broad risk disclosures.ZEUS
Registration Filing16 Dec 2025 - Q1 2025: $492.9M sales, $2.5M net income, $37M debt cut, 24.0% margin, all segments positive.ZEUS
Q1 202528 Nov 2025 - All-stock merger targets $120M synergies as Q3 shows resilience amid industry recession.ZEUS
Q3 202521 Nov 2025